NeuroRx
  • Home
  • About Us
  • Covid-19
  • NRX-100/101
  • News
  • Contact
  • Home
  • News
  • Broadcasts
  • Prof Jonathan Javitt joins i24NEWS – FDA Grants Continuation of COVID-19 Trial

Prof Jonathan Javitt joins i24NEWS – FDA Grants Continuation of COVID-19 Trial

Broadcasts
Clinical Trials Covid-19 i24 News

Share:

Categories

  • Broadcasts
  • News
  • Press releases

Tags

Accelerated Recovery ARDS Aviptadil BARDA Big Rock Partners Bipolar Depression Clinical Trials Covid-19 Critical COVID-19 Emergency Use Expanded Access Fast Track FDA High Flow Nasal Houston I-Spy i24 News NASDAQ NRX-100/101 NRXP Orphan Drug Designation Respiratory Failure RLF-100 RLF-100_002 Sever COVID-19 UCI VIP ZYESAMI Zysami

Related Posts

Press releases

NeuroRx Announces that ZYESAMI™ (Aviptadil) has Successfully Demonstrated 10-Day Accelerated Recovery from Respiratory Failure in Critically Ill Patients with Covid-19 Treated with High Flow Nasal Oxygen at 28-Day Interim Endpoint

Read more
News

Which COVID-19 treatments are showing promise? A list of potential drugs

Read more
Press releases

NeuroRx reports Initial Phase 2b/3 Study Results Demonstrating Significant Benefit of ZYESAMI™ (aviptadil) in Reducing Hospital Stay among Patients with Respiratory Failure due to Critical COVID-19

Read more

Developing innovative therapies for high-mortality unmet needs.

Company Info

  • About Us
  • RLF-100
  • NRX 100/101

Learn More

  • USA-Licensed Physicians
  • Investors
© 2020 NeuroRx, Inc.